SCHW vs VRTX · P/E 19, rev $13.55B vs P/E 30, rev $3.33B
Charles Schwab Corp (SCHW) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SCHW currently screens at market cap $164.37B and trailing P/E 18.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SCHW and VRTX stock pages for the full models.
Not investment advice.